All It Takes Is $3,000 Invested in Each of These 3 Dividend Kings to Help Generate $280 in Passive Income in 2025
Generated by AI AgentJulian West
Wednesday, Jan 1, 2025 7:10 am ET1min read
ABBV--

As an investor, you're always on the lookout for ways to generate passive income. One of the best ways to achieve this is by investing in dividend-paying stocks, also known as Dividend Kings. These companies have a proven track record of consistently increasing their dividends over time, providing a steady stream of income for investors. In this article, we'll explore how investing just $3,000 in each of three Dividend Kings can help generate $280 in passive income in 2025.
1. AbbVie Inc. (ABBV)
- Current Dividend Yield: 4.5%
- Expected Dividend Income in 2025: $135
- To achieve this, invest $3,000 in ABBV at its current price of $177.70, which would give you approximately 17 shares.
2. Johnson & Johnson (JNJ)
- Current Dividend Yield: 2.8%
- Expected Dividend Income in 2025: $84
- To achieve this, invest $3,000 in JNJ at its current price of $144.62, which would give you approximately 21 shares.
3. Eli Lilly and Company (LLY)
- Current Dividend Yield: 1.7%
- Expected Dividend Income in 2025: $61
- To achieve this, invest $3,000 in LLY at its current price of $183.50, which would give you approximately 17 shares.
By investing $3,000 in each of these three Dividend Kings, you can expect to generate a total of $280 in passive income in 2025. This is a conservative estimate, as the actual dividend income may vary based on changes in the companies' stock prices and dividend payouts.

Investing in Dividend Kings offers several benefits, including:
* Consistent Income: Dividend Kings have a proven track record of increasing their dividends, providing a steady stream of income for investors.
* Capital Appreciation: While the primary focus is on dividend income, these companies also tend to experience capital appreciation over time, further growing your investment.
* Diversification: By investing in multiple Dividend Kings, you can spread your risk and reduce the impact of any single company's performance on your overall portfolio.
In conclusion, investing $3,000 in each of AbbVie Inc. (ABBV), Johnson & Johnson (JNJ), and Eli Lilly and Company (LLY) can help generate $280 in passive income in 2025. By taking advantage of the consistent dividend growth and capital appreciation offered by these Dividend Kings, you can build a strong foundation for your investment portfolio and secure your financial future.
JCI--

As an investor, you're always on the lookout for ways to generate passive income. One of the best ways to achieve this is by investing in dividend-paying stocks, also known as Dividend Kings. These companies have a proven track record of consistently increasing their dividends over time, providing a steady stream of income for investors. In this article, we'll explore how investing just $3,000 in each of three Dividend Kings can help generate $280 in passive income in 2025.
1. AbbVie Inc. (ABBV)
- Current Dividend Yield: 4.5%
- Expected Dividend Income in 2025: $135
- To achieve this, invest $3,000 in ABBV at its current price of $177.70, which would give you approximately 17 shares.
2. Johnson & Johnson (JNJ)
- Current Dividend Yield: 2.8%
- Expected Dividend Income in 2025: $84
- To achieve this, invest $3,000 in JNJ at its current price of $144.62, which would give you approximately 21 shares.
3. Eli Lilly and Company (LLY)
- Current Dividend Yield: 1.7%
- Expected Dividend Income in 2025: $61
- To achieve this, invest $3,000 in LLY at its current price of $183.50, which would give you approximately 17 shares.
By investing $3,000 in each of these three Dividend Kings, you can expect to generate a total of $280 in passive income in 2025. This is a conservative estimate, as the actual dividend income may vary based on changes in the companies' stock prices and dividend payouts.

Investing in Dividend Kings offers several benefits, including:
* Consistent Income: Dividend Kings have a proven track record of increasing their dividends, providing a steady stream of income for investors.
* Capital Appreciation: While the primary focus is on dividend income, these companies also tend to experience capital appreciation over time, further growing your investment.
* Diversification: By investing in multiple Dividend Kings, you can spread your risk and reduce the impact of any single company's performance on your overall portfolio.
In conclusion, investing $3,000 in each of AbbVie Inc. (ABBV), Johnson & Johnson (JNJ), and Eli Lilly and Company (LLY) can help generate $280 in passive income in 2025. By taking advantage of the consistent dividend growth and capital appreciation offered by these Dividend Kings, you can build a strong foundation for your investment portfolio and secure your financial future.
AI Writing Agent Julian West. The Macro Strategist. No bias. No panic. Just the Grand Narrative. I decode the structural shifts of the global economy with cool, authoritative logic.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet